Dr. Peter W. Carter, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Tennessee, Hsc, College of Medicine (1983)
- Years since graduation
- 43
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 503
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1983Medical school: University of Tennessee, Hsc, College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
TN license MD15578 · AR license E5308 · MS license 21269
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Memorial Hospital Memphis, TN
- Jackson-Madison County General Hospital Jackson, TN
- Baptist Memorial Hospital Tipton Covington, TN
- Dyersburg Regional Medical Center Dyersburg, TN
- Baptist Memorial Hospital Union City Union City, TN
Medical groups
- Baptist Memorial Medical Group, Inc. (576 clinicians)
- Baptist Memorial Hospital-Tipton (29 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 503
- Services billed
- 1,451
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 547 | 359 |
| Established patient office or other outpatient visit, 30-39 minutes | 320 | 129 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 81 | 56 |
| New patient office or other outpatient visit, 45-59 minutes | 69 | 69 |
| Established patient office or other outpatient visit, 40-54 minutes | 53 | 40 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 49 | 36 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 38 | 36 |
| New patient office or other outpatient visit, 60-74 minutes | 28 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Memphis, TN | 105 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Memphis, TN | 86 |
| Ondansetron Odt (ondansetron) Other prescribers in Memphis, TN | 66 |
| Eliquis (apixaban) Other prescribers in Memphis, TN | 48 |
| Tamoxifen Citrate Other prescribers in Memphis, TN | 42 |
| Folic Acid Other prescribers in Memphis, TN | 40 |
| Acyclovir Other prescribers in Memphis, TN | 38 |
| Alprazolam Other prescribers in Memphis, TN | 37 |
| Xarelto (rivaroxaban) Other prescribers in Memphis, TN | 33 |
| Dexamethasone Other prescribers in Memphis, TN | 33 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 27 companies reported 85 payments worth $1,838 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $265 |
|---|---|
| GlaxoSmithKline, LLC. | $175 |
| Gilead Sciences, Inc. | $150 |
| Pfizer Inc. | $138 |
| Merck Sharp & Dohme LLC | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | $105 |
| Celgene Corporation | $101 |
| AbbVie Inc. | $91.15 |
| Food and Beverage | $1,699 |
|---|---|
| Education | $139 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Gilead Sciences, Inc. May 22, 2025 | Education Trodelvy · ONC · in-kind Company’s description;4024009;GTF;10374995 | $92.99 |
| AstraZeneca Pharmaceuticals LP Jan 28, 2025 | Education ENHERTU · Oncology · in-kind Company’s descriptionJournal Article | $25.95 |
| Genmab U.S., Inc. Jul 30, 2025 | Education Epkinly · Oncology · in-kind | $20.05 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.